Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 15.37x is 57% above its 2-year average of 9.78x, near the low end of its 2-year range (-62.71x–229.40x).
62.09% below its 12-month average of 40.54x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -11.40x.
INTEREST COVERAGE RATIO
15.37x
INTEREST COVERAGE RATIO AVG TTM
40.54x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-62.09%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+341.10%
vs the sector median at left
Q32 Bio Inc.
Market Cap
$241.39M
Interest Coverage Ratio
15.37x
TTM Avg
40.54x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$241.34M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$241.94M
Interest Coverage Ratio
0.57x
TTM Avg
0.57x
3Y Avg
0.57x
5Y Avg
0.57x
Market Cap
$239.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.01M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$236.82M
Interest Coverage Ratio
-133.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.97M
Interest Coverage Ratio
N/A
TTM Avg
28.01x
3Y Avg
25.48x
5Y Avg
25.48x
Market Cap
$235.66M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $241.39M | 15.37x | 40.54x | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $241.34M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | 0.57x | 0.57x | 0.57x | 0.57x |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.01M | -1.08x | 0.39x | 0.39x | 0.20x |
| Invivyd, Inc. (IVVD)vs › | $237.57M | N/A | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -133.11x | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | N/A | 28.01x | 25.48x | 25.48x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 0.97x | 0.97x | 0.97x | 0.97x |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | N/A | N/A | N/A | N/A |
Interest Coverage
15.4x
Debt/Equity
0.05
Current Ratio
20.30
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -11.40x |
| 2025-12-31 | 229.40x |
| 2025-09-30 | -25.26x |
| 2025-06-30 | -30.57x |
| 2025-03-31 | -40.76x |
| 2024-09-30 | -62.71x |
